Prognostic significance of lymphangiogenesis in pharyngolaryngeal carcinoma patients

BMC Cancer

Volumn 10, Issue , 2010, Pages

  Garcia Carracedo, Darío ^a   Rodrigo, Juan P ^a,b   Astudillo, Aurora ^a,b   Nieto, Carlos S ^a,b   Gonzalez, Maria V ^a  

^a DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

^b HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY D2-40; MONOCLONAL ANTIBODY KI 67; PODOPLANIN; TUMOR MARKER; DNA; KI 67 ANTIGEN; MONOCLONAL ANTIBODY;

ARTICLE; CANCER STAGING; CELL PROLIFERATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOPHARYNX CARCINOMA; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; LYMPH VESSEL; LYMPH VESSEL ENDOTHELIUM; LYMPHANGIOGENESIS; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SURVIVAL RATE; TUMOR; TUMOR EMBOLISM; TUMOR VOLUME; ADULT; AGED; ENZYME IMMUNOASSAY; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; LARYNX TUMOR; METABOLISM; METASTASIS; MIDDLE AGED; PATHOLOGY; PHARYNX CANCER; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; CARCINOMA, SQUAMOUS CELL; CELL PROLIFERATION; DNA, NEOPLASM; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOENZYME TECHNIQUES; KI-67 ANTIGEN; LARYNGEAL NEOPLASMS; LYMPHANGIOGENESIS; LYMPHATIC METASTASIS; LYMPHATIC VESSELS; MALE; MIDDLE AGED; NEOPLASM STAGING; PHARYNGEAL NEOPLASMS; PROGNOSIS; SURVIVAL RATE;

EID: 77955285638     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-416     Document Type: Article

References (20)

1. Stewart B, Kleihues P. World Cancer Report 2003, Geneva: International Agency for Research on Cancer.
2. Wicki A, Christofori G. The potential role of podoplanin in tumour invasion. British journal of cancer 2007, 96(1):1-5. 10.1038/sj.bjc.6603518, 2360213, 17179989.
3. Clarijs R, Ruiter DJ, de Waal RM. Lymphangiogenesis in malignant tumours: Does it occur?. The Journal of pathology 2001, 193(2):143-146. 10.1002/path.808, 11180158.
4. Williams CS, Leek RD, Robson AM, Banerji S, Prevo R, Harris AL, Jackson DG. Absence of lymphangiogenesis and intratumoural lymph vessels in human metastatic breast cancer. The Journal of pathology 2003, 200(2):195-206. 10.1002/path.1343, 12754740.
5. Beasley NJ, Prevo R, Banerji S, Leek RD, Moore J, van Trappen P, Cox G, Harris AL, Jackson DG. Intratumoral lymphangiogenesis and lymph node metastasis in head and neck cancer. Cancer research 2002, 62(5):1315-1320.
6. Pepper MS. Lymphangiogenesis and tumor metastasis: myth or reality?. Clin Cancer Res 2001, 7(3):462-468.
7. Leu AJ, Berk DA, Lymboussaki A, Alitalo K, Jain RK. Absence of functional lymphatics within a murine sarcoma: a molecular and functional evaluation. Cancer research 2000, 60(16):4324-4327.
8. Stacker SA, Caesar C, Baldwin ME, Thornton GE, Williams RA, Prevo R, Jackson DG, Nishikawa S, Kubo H, Achen MG. VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nature medicine 2001, 7(2):186-191. 10.1038/84635, 11175849.
9. Evangelou E, Kyzas PA, Trikalinos TA. Comparison of the diagnostic accuracy of lymphatic endothelium markers: Bayesian approach. Mod Pathol 2005, 18(11):1490-1497. 10.1038/modpathol.3800457, 15990898.
10. Van der Auwera I, Cao Y, Tille JC, Pepper MS, Jackson DG, Fox SB, Harris AL, Dirix LY, Vermeulen PB. First international consensus on the methodology of lymphangiogenesis quantification in solid human tumours. British journal of cancer 2006, 95(12):1611-1625. 10.1038/sj.bjc.6603445, 2360768, 17117184.
11. Kahn HJ, Marks A. A new monoclonal antibody, D2-40. for detection of lymphatic invasion in primary tumors. Laboratory investigation; a journal of technical methods and pathology 2002, 82(9):1255-1257.
12. McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM. Reporting recommendations for tumor marker prognostic studies (REMARK). Journal of the National Cancer Institute 2005, 97(16):1180-1184. 10.1093/jnci/dji237, 16106022.
13. Yuan P, Temam S, El-Naggar A, Zhou X, Liu DD, Lee JJ, Mao L. Overexpression of podoplanin in oral cancer and its association with poor clinical outcome. Cancer 2006, 107(3):563-569. 10.1002/cncr.22061, 16804930.
14. Audet N, Beasley NJ, MacMillan C, Jackson DG, Gullane PJ, Kamel-Reid S. Lymphatic vessel density, nodal metastases, and prognosis in patients with head and neck cancer. Archives of otolaryngology--head & neck surgery 2005, 131(12):1065-1070.
15. Kyzas PA, Geleff S, Batistatou A, Agnantis NJ, Stefanou D. Evidence for lymphangiogenesis and its prognostic implications in head and neck squamous cell carcinoma. The Journal of pathology 2005, 206(2):170-177. 10.1002/path.1776, 15846845.
16. Franchi A, Gallo O, Massi D, Baroni G, Santucci M. Tumor lymphangiogenesis in head and neck squamous cell carcinoma: a morphometric study with clinical correlations. Cancer 2004, 101(5):973-978. 10.1002/cncr.20454, 15329906.
17. Maula SM, Luukkaa M, Grenman R, Jackson D, Jalkanen S, Ristamaki R. Intratumoral lymphatics are essential for the metastatic spread and prognosis in squamous cell carcinomas of the head and neck region. Cancer research 2003, 63(8):1920-1926.
18. Kyzas PA, Stefanou D, Batistatou A, Agnantis NJ, Nakanishi Y, Hirohashi S, Charalabopoulos K. Dysadherin expression in head and neck squamous cell carcinoma: association with lymphangiogenesis and prognostic significance. The American journal of surgical pathology 2006, 30(2):185-193. 10.1097/01.pas.0000178090.54147.f8, 16434892.
19. Longatto Filho A, Oliveira TG, Pinheiro C, de Carvalho MB, Curioni OA, Mercante AM, Schmitt FC, Gattas GJ. How useful is the assessment of lymphatic vascular density in oral carcinoma prognosis?. World J Surg Oncol 2007, 5:140. 10.1186/1477-7819-5-140, 2228303, 18072963.
20. Sobin LH, Wittekind C. TNM classification of malignant tumors 2002, New York: Wiley-Liss, 6.